ÂÜÀòÂÒÂ×

Caroline Stout specializes in operational and scientific analysis at EcoR1 Capital LLC. In her role as an EcoR1 Analyst, Ms. Stout informs the fund’s investment decisions by assessing clinical data and corporate insights to gain broad insights into biotechnology companies, markets and emerging science. She previously worked as an Investment Banking Analyst at Credit Suisse in New York, performing due diligence and financial valuation analysis for healthcare companies. She has experience working on a range of transactions in the healthcare and biotechnology sectors, including multi-billion dollar leveraged buyouts, initial public offerings and follow-on equity raises. Ms. Stout graduated magna cum laude from Georgetown University with a Bachelor of Arts in Economics, a Pre-Medical concentration, and Cognitive Science minor.